RM Plc FY Adj. Profit Rises; Revenue Up 12% - Quick Facts

RM plc (RM.L) reported that its fiscal year adjusted operating profit increased by 22.5% to 18.5 million pounds from 15.1 million pounds, prior year, driven by revenue growth partially offset by increased operating costs. Adjusted EPS was 16.4 pence compared to 13.6 pence.

Pretax profit declined to 5.6 million pounds from 9.5 million pounds. Earnings per share was 5.0 pence compared to 9.1 pence.

For the year ended 30 November 2021, Group revenue increased by 11.6% to 210.9 million pounds from 189.0 million pounds, driven by strong trading in RM Resources which recovered quickly following the re-opening of UK schools in March 2021.

Neil Martin, Chief Executive of RM, said: "RM delivered a satisfactory financial performance in another year impacted by COVID-19. While the current environment remains uncertain, market trends are developing positively for the longer-term outlook of RM."

The Board recommended the payment of a final dividend of 3.0 pence share, which together with the interim dividend would amount to a total of 4.7 pence share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT